1. AHRO : Austin Health Research Online

Niall C Tebbutt

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Niall C Tebbutt
Full Name
Tebbutt, Niall C
 
Department
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Tebbutt, Niall C
Subject:  Middle Aged
Date Issued:  2013

Results 1-5 of 5 (Search time: 0.011 seconds).

Publication YearTitleAuthor(s)
112-Dec-2013Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.Jonker, D J; Karapetis, C S; Harbison, C; O'Callaghan, Christopher J ; Tu, D; Simes, R J; Malone, D P; Langer, C; Tebbutt, Niall C ; Price, Timothy J; Shapiro, J; Siu, L L; Wong, R P W; Bjarnason, G; Moore, M J; Zalcberg, John R; Khambata-Ford, S
23-Dec-2013Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.Greenhalf, William; Ghaneh, Paula; Neoptolemos, John P; Palmer, Daniel H; Cox, Trevor F; Lamb, Richard F; Garner, Elizabeth; Campbell, Fiona; Mackey, John R; Costello, Eithne; Moore, Malcolm J; Valle, Juan W; McDonald, Alexander C; Carter, Ross; Tebbutt, Niall C ; Goldstein, David B; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Charnley, Richard M; Lacaine, François; Scarfe, Andrew G; Middleton, Mark R; Anthoney, Alan; Halloran, Christopher M; Mayerle, Julia; Oláh, Attila; Jackson, Richard; Rawcliffe, Charlotte L; Scarpa, Aldo; Bassi, Claudio; Büchler, Markus W
34-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S 
416-Sep-2013Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.Ohtsu, Atsushi; Ajani, Jaffer A; Bai, Yu-Xian; Bang, Yung-Jue; Chung, Hyun-Cheol; Pan, Hong-Ming; Sahmoud, Tarek; Shen, Lin; Yeh, Kun-Huei; Chin, Keisho; Muro, Kei; Kim, Yeul Hong; Ferry, David; Tebbutt, Niall C ; Al-Batran, Salah-Eddin; Smith, Heind; Costantini, Chiara; Rizvi, Syed; Lebwohl, David; Van Cutsem, Eric
514-Feb-2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial.Tebbutt, Niall C ; Parry, M M; Zannino, D; Strickland, A H; Van Hazel, G A; Pavlakis, N; Ganju, V; Mellor, D; Dobrovic, Alexander ; Gebski, V J